Figure 1.
Consort diagram for participants who developed hospitalized or treated PAD (revascularization procedure or hospitalized) during the randomized phase of ALLHAT and were eligible for long-term mortality follow-up. *Wilcoxon test for the equality of survival function probability values are: amlodipine vs. chlorthalidone P = 0.099; lisinopril vs. chlorthalidone P = 0.915.